Radical prostatectomy use in men with localized, high-risk prostate cancer is increasing.1 While the procedure is curative for some, a substantial proportion of men will experience prostate-specific antigen (PSA) persistence or a delayed increase in PSA, a situation known as biochemical recurrence. This evidence concerns the gene KLK3 and prostate cancer.